Allyson L. Parr

Prognostic Value of Thymidylate Synthase, Ki-67, and <i>p53</i> in Patients With Dukes’ B and C Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative Study

Carmen J. Allegra, Soon Young Paik, Linda H. Colangelo et al. · Journal of Clinical Oncology · 2003 · 283 citations

Medicine, Oncology, Chemotherapy +16

Evaluation of Biologic End Points and Pharmacokinetics in Patients With Metastatic Breast Cancer After Treatment With Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

Antoinette R. Tan, Xiaowei Yang, Stephen M. Hewitt et al. · Journal of Clinical Oncology · 2004 · 177 citations

Medicine, Oncology, Pharmacology +17

Investigation of the Prognostic and Predictive Value of Thymidylate Synthase, p53, and Ki-67 in Patients With Locally Advanced Colon Cancer

Carmen J. Allegra, Allyson L. Parr, Lester E. Wold et al. · Journal of Clinical Oncology · 2002 · 173 citations

Medicine, Oncology, Pathology +16

Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors

William L. Dahut, Nehal J. Lakhani, James L. Gulley et al. · Cancer Biology & Therapy · 2006 · 156 citations

Pharmacy, Oncology, Pharmacology +15

The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.

David H. Harpole, M B Moore, James E. Herndon et al. · PubMed · 2001 · 90 citations

Medicine, Oncology, Radiation Oncology +17